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Abstract In the present study, we describe a role for cyclic 
GMP (cGMP) in the signalling pathway that leads from 
tz-adrenergic receptor activation to intracellular Ca 2+ mobiliza- 
tion in rat lacrimal acinar cells. The a-adrenergic agonist, 
phenylephrine, stimulates intracellular Ca 2+ release which is 
blocked by inhibitors of guanylate cyclase and cGMP-dependent 
protein kinase Ia. The membrane-permeable cGMP analogues, 
dibutyryl-cGMP and 8-bromo-cGMP, potentiate (= 5-fold) the 
2+ Ca response to submaximal phenylephrine stimulation. In 
contrast, the same cGMP analogues have no effect on cyclic 
ADP-ribose-evoked Ca 2+ release from permeabilized lacrimal 
acinar cells. Collectively, these findings suggest hat cGMP, via 
cGMP-dependent protein kinase Ict, is required for intraceHular 
Ca 2÷ release following c~-adrenergic receptor activation in 
lacrimal acinar cells. 
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1. Introduction 
Cyclic ADP-ribose (cADPR) is a naturally occurring 
metabolite of the pyridine nucleotide I3-NAD + that mobilizes 
Ca 2+ via ryanodine-sensitive intracellular Ca2+-induced Ca 2+ 
release channels in a number of cell types [1,2], including 
exocrine acinar cells [3,5]. Although cADPR has Ca 2÷ mobi- 
lizing activity, it still remains largely unknown whether it 
functions as a second messenger for extracellular stimuli. 
There are indications that cADPR may function as a second 
messenger in lacrimal acinar cells in response to a-adrenergic 
receptor activation, since phenylephrine stimulates Ca 2+ re- 
lease from intracellular stores via a ryanodine-sensitive me- 
chanism, which is not associated with increased production 
of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) [6]. However, no 
unequivocal information about the cellular components con- 
stituting this new signalling pathway is yet available. 
One clue as to how cADPR synthesis may be regulated has 
come from a study demonstrating that cGMP mobilizes Ca 2+ 
in sea urchin eggs by stimulating cADPR synthesis and it was 
suggested that cGMP activates, via a cGMP-dependent pro- 
tein kinase, the ADP-ribosylcyclase that converts I3-NAD + to 
cADPR [7]. These observations imply that agonists interacting 
with receptors which are themselves intrinsic guanylate cy- 
clases, or nitric oxide (NO) which activates oluble guanylate 
cyclases, may stimulate cADPR production. In the present 
study we therefore investigated the possibility that cGMP is 
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involved in Ca 2+ mobilization from intracellular stores in la- 
crimal acinar cells following a-adrenergic receptor activation. 
2. Materials and methods 
2.1. Chemicals 
Fura-2 acetoxymethyl ester (fura-2/AM) and fura-2 pentapotassium 
salt were supplied from Molecular Probes (Eugene, OR). cADP-ribose 
was from Amersham (Buckinghamshire, UK). Ins(1,4,5)P3 was from 
Alomone Labs (Jerusalem, Israel). 8-(4-Chlorophenylthio)-guanosine- 
Y,5'-cyclic monophosphorothioate (Rp-8-pCPT-cGMPS) was ob- 
tained from Biolog Life Science Institute (Bremen, Germany). 
LY83583 and NG-nitro-L-arginine were from Research Biochemicals 
Inc. (Natick, MA). All other chemicals were obtained from Sigma 
Chemicals (St. Louis, MO). 
2.2. Cell preparation and Ca 2+ measurements 
Rat lacrimal glands were extirpated from male Wistar rats (130 g) 
and dispersed into acini by collagenase and hyaluronidase digestion, 
as described previously [6]. After cell preparation, the acini were ready 
for use and all experiments in the present study were performed within 
lh .  
For measurements of the intracellular free Ca 2+ concentration 
([Ca2+]i) in intact cells in suspension, the acini were incubated with 
2 laM fura-2/AM (cytocrit = 1%) for 30 min in a shaking water bath 
at 37°C. The fura-2 loaded cells were washed and resuspended in a 
HEPES-buffered Krebs-Ringer medium containing (in mM): 142 
Na +, 5 K +, 1 Ca 2+, 1 Mg 2+, 125 CI , 20 HCO~-, 4 HPO]-/H2PO~, 
5 HEPES (pH 7.3), before being transferred to a thermostatically 
controlled cuvette (37°C) with a stirring device mounted on a Per- 
kin-Elmer LS5B fluorescence spectrophotometer. Changes in [Ca2+]~ 
were measured as described previously [6]. 
For measurements of Ca 2+ release from permeabilized lacrimal aci- 
nar cells, aliquots of cells were permeabilized (3 min at 37°C) in 2.5 ml 
of intracellular-like (IC) solution containing (in mM): 20 Na +, 100 
K +, 1 Mg 2+, 120 CI-, 1 SO]-, 20 HEPES (pH 7.20) and 22.5 ~g/ml 
saponin. Following permeabilization, the cells were washed and resus- 
pended in 100 ~tl of IC solution before being transferred to a cuvette 
containing 2.4 ml of IC solution with 1 mM ATP, 10 U/ml creatine 
phosphokinase, 10 mM phosphocreatine and 1 mM fura-2 pentapo- 
tassium salt added and Ca 2+ release was measured as described pre- 
viously [4]. 
2.3. Data analysis 
Results are presented as mean values +S.D. for the indicated 
number of experiments. Statistical significance's were evaluated using 
Student's t-test for paired observations. 
3. Results and discussion 
Fig. 1A shows the effect of sequential stimulation with max- 
imal concentrations of phenylephrine (20 ~tM) and acetylchol- 
ine (10 ~tM) on [Ca2+]i in a suspension of rat lacrimal acinar 
cells. Phenylephrine stimulated a rapid transient rise in [CaZ+]i 
from a resting level of 133-352 nM, which declined towards a 
plateau level slightly higher than the pre-stimulatory [Ca2+]i. 
Subsequent stimulation with acetylcholine induced a new 
transient rise in [Ca2+]i, which reached a peak of 756 nM 
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Fig. 1. Effect of LY83583 and Rp-8-pCPT-cGMPS on the changes 
in [Ca2+]i evoked by sequential phenylephrine and acetylcholine 
stimulations. Changes in [Ca2+]i in suspensions of lacrimal acinar 
cells in (A) control cells or in cells pre-treated with (B) 20 /aM 
LY83583 or with (C) 50 /aM Rp-8-pCPT-cGMPS for 3 min before 
stimulation with 20 /aM phenylephrine (Phe) followed by 10 txM 
acetylcholine (ACh). The traces are representatives of 5-7 experi- 
ments from three different cell preparations. 
(Fig. 1A). Similar transient rises in [Ca2+]i were observed in a 
series of seven experiments with the amplitude of the phenyl- 
ephrine-induced rise in [CaZ+]i amounting in average to 39% 
of that observed following acetylcholine stimulation (Table 1). 
We have previously demonstrated that the observed rise in 
[Ca2+]i in suspensions of rat lacrimal acinar cells following 
stimulation with phenylephrine and acetylcholine is due to 
mobilization from intracellular stores and not from influx of 
Ca 2+ since both agonists induced changes in [CaZ+]i of similar 
magnitudes when measured in either Ca~+-free or CaZ+-con - 
taining media [6]. The acetylcholine-evoked rise in [Ca~+]i 
in lacrimal acinar cells involves activation of phospholipase 
C and Ins(1,4,5)P3 production [6,8]. In contrast, the phenyl- 
ephrine-induced Ca 2+ mobilization is mediated without any 
inositol phosphate production and therefore a different signal- 
ling pathway seems to be activated following ct-adrenergic 
receptor activation [6,9]. In this context, it has been suggested 
that cADPR could act as the Ca 2+ mobilizing second messen- 
ger activated by ~t-adrenergic receptor stimulation [4,6]. 
It was recently demonstrated that cGMP is an endogenous 
regulator of cADPR synthesis in sea urchin eggs [7] and we 
therefore tested the effect of the specific guanylate cyclase 
inhibitor, LY83583, on the phenylephrine- and acetylchol- 
ine-induced rise in [Ca2+]i. Pre-treatment of lacrimal acinar 
cells with 20 mM LY83583 for 3 min had no effect on the 
resting [Ca2+]i but strongly and selectively inhibited the phen- 
ylephrine-evoked [Ca2+]i response by 93+2% (P<0.001, 
n=6) (Fig. 1B). In accordance with previous observations 
on pancreatic acinar cells [10,11], LY83583 had no significant 
effect on the initial Ca 2+ response following acetylcholine 
stimulation (Table 1). 
These results suggest a crucial role for cGMP in the phen- 
ylephrine-induced Ca2+ response and we investigated the pos- 
sibility that cGMP mediates its action through activation of a 
cGMP-dependent protein kinase. Inhibition of cGMP-depen- 
dent protein kinase Ict by pre-treatment for 3 rain of lacrimal 
acinar cells with 50 ~tM of the membrane-permeant inhibitor 
Rp-8-pCPT-cGMPS [2,12] strongly inhibited the phenylephr- 
ine-evoked rise in [Ca2+]i (Fig. 1C). In a series of five experi- 
ments, we found that Rp-8-pCPT-cGMPS inhibited the phe- 
nylephrine-induced rise in [Ca2+]i by 75+1% (P<0.001) 
without affecting the amplitude of the acetylcholine-induced 
[Ca2+]i response (Table 1). 
These data suggest hat phenylephrine promotes Ca 2+ re- 
lease from intracellular stores through a pathway involving 
activation of guanylate cyclase and cGMP-dependent protein 
kinase Ia. In order to further explore the role that cGMP 
plays in the cascade of events initiated by ct-adrenergic recep- 
tor activation, we monitored the effects of membrane-per- 
meant forms of cGMP on the phenylephrine- and acetylchol- 
ine-induced rise in [Ca2+]i. Exposure of lacrimal acinar cells to 
1 mM dibutyryl-cGMP did not affect the resting [Ca2+]i but 
strongly potentiated the increase in [Ca2+]i following stimula- 
tion with a submaximal phenylephrine concentration (5 ~tM) 
(Fig. 2A,B). A submaximal gonist concentration was applied 
in order to fully reveal the potentiating effect of cGMP on 
[Ca2+]i. In accordance with the results depicted in Fig. 1, the 
potentiating effect of cGMP on [Ca2+]i was specific for 
Table 1 
Effect of inhibitors of guanylate cyclase and cGMP-dependent pro- 




Phe (20 txM) 
LY83583 (20/aM)+Phe (20/aM) 
Rp-8-pCPT-cGMPS (50 IxM)+Phe (20 ~tM) 
ACh (10/aM) 
LY83583 (20 ~M)+ACh (10 JaM) 
Rp-8-pCPT-cGMPS (50 ~M)+ACh (10 ~tM) 
202 + 37 (7) 
14+ 6 (6)* 
55 _+ 11 (5)* 
498 + 75 (7) 
432_+ 29 (6) n.s. 
538 + 48 (5) n.s. 
A[Ca2+]i is the difference between peak and basal [Ca2+]i. 
Phe, phenylephrine; ACh, acetylcholine. LY83583 and Rp-8-pCPT- 
cGMPS were added 3 min before agonist stimulation. 
*P < 0.001 ; n.s. (not significant). 
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Fig. 2. Cyclic GMP selectively potentiate the phenylephrine-evoked 
increase in [Ca2+]i. Effect of sequential phenylephrine (Phe; 5 I.tM) 
and acetylcholine (ACh; 10 gM) stimulation in either (A) control 
cells or in (B) cells pre-treated with 1 mM dibutyryl-cGMP for 
3 min. The traces are representatives of three and four individual 
experiments from at least hree different cell preparations. 
c~-adrenergic receptor activation and did not affect the acet- 
ylcholine-induced rise in [Ca2+]i (Fig. 2B and Table 2). Similar 
potentiating effects on intracellular Ca 2+ handling were ob- 
served in cells pre-treated with 8-bromo-cGMP, but not with 
8-bromo-cAMP (Table 2). 
These results indicate that a rise in the intracellular cGMP 
concentration is not per se sufficient to stimulate an increase 
in [Ca2+]i and that c~-adrenergic receptor activation isessential 
for revealing the potentiating effect of cGMP. It has been 
suggested that cADPR might mediate its effects through a 
path involving NO and with cGMP as an intermediate [2]. 
Accordingly, NO would activate soluble guanylate cyclases, 
resulting in elevated cytoplasmic GMP levels. This would 
lead to stimulation of cGMP-dependent protein kinase result- 
ing in enhanced cADPR production [2]. However, application 
of various concentrations (1-500 gM) of the NO-synthase 
inhibitor, NC-nitro-L-arginine, to lacrimal acinar cells had 
Table 2 
Effect of pharmacological interventions on phenylephrine-induced 
changes in [Ca2+]i 
Condition Parameter 
A[Ca2+]i (nM) 
Phe (5 I.tM) 72 + 20 (5) 
db-cGMP (1 mM)+Phe (5 I.tM) 314+ 81 (3)* 
8-Br-cGMP (1 mM)+Phe (5 ~tM) 359 + 64 (4)** 
8-Br-cAMP (1 mM)+Phe (5 I.tM) 96 + 40 (3) n.s. 
A[Ca2+]i is the difference between peak and basal [Ca2+]i. 
Phe, phenylephrine; db-cGMP, dibutyryl-cGMP; 8-Br-cGMP, 8-bro- 
mo-cGMP; 8-Br-cAMP, 8-bromo-cAMP. db-cGMP, 8-Br-cGMP and 
8-Br-cAMP were added 3 min before phenylephrine stimulation. 
*P < 0.025; **P < 0.005; n.s. (not significant). 
no effect on either the resting cytoplasmic Ca 2+ concentration 
or the phenylephrine-evoked rise in [Ca2+]i (data not shown). 
Thus, it appears that the potentiating effect of cGMP on the 
phenylephrine-induced [Ca2+]i response in lacrimal acinar 
cells does not involve activation of soluble guanylate cyclases 
and that the effect of LY83583 (see Fig. 1) on this signalling 
pathway must result from inhibition of another type of gua- 
nylate cyclase. 
We have previously demonstrated that the effect of phenyl- 
ephrine on [Ca2+]i nvolves activation of ryanodine-sensitive 
Ca 2+ release channels and proposed that cADPR might med- 
iate this process [6]. Therefore, we measured Ca 2÷ release 
from permeabilized lacrimal acinar cells in order to explore 
the possibility that the potentiating effect of cGMP results 
from sensitization of these intracellular Ca 2+ release channels. 
As shown in Fig. 3, this is unlikely to be the case since cGMP 
(in the presence of I3-NAD +, the substrate for the cADPR- 
synthesizing enzyme, ADP-ribosyl cyclase) did not by itself 
stimulate Ca 2+ release, nor did it affect Ca z+ release in re- 
sponse to subsequent cADPR and Ins(1,4,5)P3 stimulations. 
The Ca 2+ responses following the addition of 5 ~tM cADPR 
amounted in control cells to 122+23 nM (n=3) and to 
127+27 nM @=4) in cells pre-treated with 1 mM cGMP. 
The corresponding Ca 2+ responses following the addition of 
5 mM Ins(1,4,5)P3 amounted to 508 + 75 nM (n = 3) in control 
cells and to 481 + 24 nM (n = 4) in cells incubated with cGMP 
(not significant). Furthermore, treatment of intact acinar cells 
with 1 mM dibutyryl-cGMP for 3 min before permeabiliza- 
tion had no effect on the extent of Ca 2+ release in response to 
cADPR stimulation (data not shown). 
The data in the present study indicate that cGMP and 
activation of cGMP-dependent protein kinase Ia are essential 
for intracellular Ca 2+ mobilization following c~-adrenergic re- 
ceptor activation in lacrimal acinar cells. These findings are in 
line with an earlier study demonstrating cGMP-mediated 
cADPR production in sea urchin eggs [7]. The potentiating 
effect of cGMP on the phenylephrine-evoked rise in [Ca2+]i in 
lacrimal acinar cells does not occur via sensitization of rya- 
nodine-sensitive intracellular Ca 2+ release channels, since 
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Fig. 3. Ca 2+ release from permeabilized lacrimal acinar cells follow- 
ing addition of cADPR and Ins(1,4,5)P3. Aliqots of cells were per- 
meabilized with saponin and following Ca 2+ accumulation a d base- 
line stabilization, I~-NAD + (1 mM, final concentration) was added. 
After 3 min cGMP (1 mM) was added followed by 5 I.tM cADPR 
and 5 I.tM Ins(1,4,5)P3. The trace is representative of four individual 
experiments from four different cell preparations. 
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to cADPR stimulation. However, it has been demonstrated 
that cGMP-dependent protein kinases can induce rapid phos- 
phorylation (and sensitization) of ryanodine-sensitive Caz+ 
channels [13,14]. Therefore, it seems more likely that the po- 
tentiating effect of cGMP on the phenylephrine-evoked risein 
[Ca2+]i results from an enhanced cADPR production. At the 
present ime it is not clear how cGMP can potentiate the 
phenylephrine-evoked Ca 2+ response without in itself stimu- 
lating a rise in [Ca2+]i. However, it seems that c~-adrenergic 
receptor activation is essential for initiating the cascade of 
reactions leading to Ca 2+ mobilization from intracellular 
stores and that cGMP somehow enhances the flow of infor- 
mation through this signalling pathway. Thus, it appears that 
cGMP has a permissive rather than a decisive role in the sig- 
nalling pathway stimulated by ~-adrenergic receptor activa- 
tion in lacrimal acinar cells. 
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